Showing 25 to 36 of 41 results


Low Cervical Cancer Screening in Spain Highlights HPV Risk
A low participation rate in Spain's cervical cancer screening program, using HPV testing since 2019, raises concerns about increased cancer cases, given the high global prevalence of HPV and its link to various cancers. A new study reveals 7.4% oral HPV prevalence in Europe and the US, with higher r...
Low Cervical Cancer Screening in Spain Highlights HPV Risk
A low participation rate in Spain's cervical cancer screening program, using HPV testing since 2019, raises concerns about increased cancer cases, given the high global prevalence of HPV and its link to various cancers. A new study reveals 7.4% oral HPV prevalence in Europe and the US, with higher r...
Progress
20% Bias Score


Sunak Backs Nationwide Prostate Cancer Screening
Former UK Prime Minister Rishi Sunak is endorsing a campaign for nationwide prostate cancer screening in the UK, driven by a new, highly accurate blood test and the impact of the disease on his personal life, aiming to save thousands of lives.
Sunak Backs Nationwide Prostate Cancer Screening
Former UK Prime Minister Rishi Sunak is endorsing a campaign for nationwide prostate cancer screening in the UK, driven by a new, highly accurate blood test and the impact of the disease on his personal life, aiming to save thousands of lives.
Progress
44% Bias Score


Colorectal Cancer Screening Recommendations and Mortality Rates
The American Cancer Society recommends colorectal cancer screening starting at age 45 for average-risk individuals, continuing to age 75, significantly reducing mortality rates; however, deaths are rising among those under 55.
Colorectal Cancer Screening Recommendations and Mortality Rates
The American Cancer Society recommends colorectal cancer screening starting at age 45 for average-risk individuals, continuing to age 75, significantly reducing mortality rates; however, deaths are rising among those under 55.
Progress
48% Bias Score


Netherlands Sees Sharp Rise in Cancer Diagnoses, Especially Prostate Cancer
In 2024, 130,000 people in the Netherlands were diagnosed with cancer—a 3,000 increase from 2023—largely due to population growth and aging. Prostate cancer diagnoses surged, nearing breast cancer numbers, highlighting the need for improved early detection, as many cases present with advanced metast...
Netherlands Sees Sharp Rise in Cancer Diagnoses, Especially Prostate Cancer
In 2024, 130,000 people in the Netherlands were diagnosed with cancer—a 3,000 increase from 2023—largely due to population growth and aging. Prostate cancer diagnoses surged, nearing breast cancer numbers, highlighting the need for improved early detection, as many cases present with advanced metast...
Progress
60% Bias Score


France Launches Pilot Program for Lung Cancer Screening
France is launching a 6 million euro pilot program involving 20,000 smokers/ex-smokers (50-74 years old) for lung cancer screening using low-dose CT scans and cessation support, aiming to inform nationwide screening by 2030.
France Launches Pilot Program for Lung Cancer Screening
France is launching a 6 million euro pilot program involving 20,000 smokers/ex-smokers (50-74 years old) for lung cancer screening using low-dose CT scans and cessation support, aiming to inform nationwide screening by 2030.
Progress
48% Bias Score


Bowel Cancer Rates Surge Among Young Adults in England
Analysis of NHS data reveals a sharp rise in bowel cancer diagnoses among 40-44 year olds in England, increasing by 57 percent in men and 50 percent in women between 2019 and 2022, prompting a reduction in the bowel cancer screening age to 50 due to concerns about lifestyle factors.
Bowel Cancer Rates Surge Among Young Adults in England
Analysis of NHS data reveals a sharp rise in bowel cancer diagnoses among 40-44 year olds in England, increasing by 57 percent in men and 50 percent in women between 2019 and 2022, prompting a reduction in the bowel cancer screening age to 50 due to concerns about lifestyle factors.
Progress
44% Bias Score

Ontario Switches to HPV Testing for Cervical Cancer Screening
Ontario is replacing Pap tests with HPV tests for cervical cancer screening, starting October 2nd, 2023, due to the HPV test's higher effectiveness and ability to be performed less frequently, aiming to reduce rising cervical cancer incidence rates; this aligns with national and international trends...

Ontario Switches to HPV Testing for Cervical Cancer Screening
Ontario is replacing Pap tests with HPV tests for cervical cancer screening, starting October 2nd, 2023, due to the HPV test's higher effectiveness and ability to be performed less frequently, aiming to reduce rising cervical cancer incidence rates; this aligns with national and international trends...
Progress
44% Bias Score

NHS Launches First Breast Cancer Screening Awareness Campaign
The NHS England launched its first breast cancer screening awareness campaign to increase participation, which is currently at 64.6%, aiming to reach 80% by 2025-26 to detect thousands more cancers at an early stage and save lives.

NHS Launches First Breast Cancer Screening Awareness Campaign
The NHS England launched its first breast cancer screening awareness campaign to increase participation, which is currently at 64.6%, aiming to reach 80% by 2025-26 to detect thousands more cancers at an early stage and save lives.
Progress
40% Bias Score

France Tackles Cervical Cancer Disparities Despite Vaccination and Screening Progress
France reports over 3,100 new cervical cancer cases and 1,100 deaths annually; despite increased HPV vaccination coverage (54.6% for one dose among 15-year-old girls in 2023) and screening participation (59.5% coverage 2020-2022), significant regional disparities persist, highlighting the need for i...

France Tackles Cervical Cancer Disparities Despite Vaccination and Screening Progress
France reports over 3,100 new cervical cancer cases and 1,100 deaths annually; despite increased HPV vaccination coverage (54.6% for one dose among 15-year-old girls in 2023) and screening participation (59.5% coverage 2020-2022), significant regional disparities persist, highlighting the need for i...
Progress
16% Bias Score

Rise in Prostate Cancer Diagnoses Raises Questions About Screening and Treatment
Prostate cancer has become the most common cancer diagnosis in England, prompting increased PSA testing despite studies showing limited effectiveness of widespread screening and treatment uncertainties highlighted by the British ProtecT study.

Rise in Prostate Cancer Diagnoses Raises Questions About Screening and Treatment
Prostate cancer has become the most common cancer diagnosis in England, prompting increased PSA testing despite studies showing limited effectiveness of widespread screening and treatment uncertainties highlighted by the British ProtecT study.
Progress
36% Bias Score

Rising Early-Onset Cancers Challenge Canadian Healthcare
Rates of early-onset cancers are rising globally, particularly colorectal cancer among Gen X and millennials in Canada, who experience rates double those of previous generations; factors include lifestyle, environment, and reproductive changes, straining healthcare systems designed for older patient...

Rising Early-Onset Cancers Challenge Canadian Healthcare
Rates of early-onset cancers are rising globally, particularly colorectal cancer among Gen X and millennials in Canada, who experience rates double those of previous generations; factors include lifestyle, environment, and reproductive changes, straining healthcare systems designed for older patient...
Progress
44% Bias Score

AI and Laser Analysis Improve Early Breast Cancer Detection
Researchers developed a 98% accurate, non-invasive laser analysis and machine learning method for detecting stage 1a breast cancer, surpassing liquid biopsy; AI is also improving mammogram analysis, increasing detection rates and offering hope for better patient outcomes.

AI and Laser Analysis Improve Early Breast Cancer Detection
Researchers developed a 98% accurate, non-invasive laser analysis and machine learning method for detecting stage 1a breast cancer, surpassing liquid biopsy; AI is also improving mammogram analysis, increasing detection rates and offering hope for better patient outcomes.
Progress
28% Bias Score
Showing 25 to 36 of 41 results